Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ChordArt System Study for the Treatment of Mitral Regurgitation Due to Leaflet Prolapse or Flail

NCT03581656 is registered in ClinicalTrials.gov with CoreMedic GmbH as lead sponsor.

NCT NCT03581656
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03581656 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ChordArt System Study for the Treatment of Mitral Regurgitation Due to Leaflet Prolapse or Flail
Lead sponsor
CoreMedic GmbH
Phase
Not applicable
Overall status
Unknown status
Start date
March 21, 2018
Completion date
December 31, 2023
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mitral regurgitation, mitral valve insufficiency, mitral valve repair